Live Nation Entertainment, Inc.
Thesis
Live Nation is poised for a strong recovery post-COVID, with expectations of event attendance rebounding to pre-pandemic levels. The company's strong balance sheet and market position provide a solid foundation for growth, and the current valuation presents an attractive risk/reward scenario for investors.
Did it work?
The long thesis on Live Nation's post-COVID recovery played out decisively: the stock returned +505.5% over the ~70 months since the pitch, far exceeding typical market returns. The core thesis elements — attendance rebounding to pre-pandemic levels and the company leveraging its market position for growth — were confirmed as live events demand surged post-pandemic. With nearly six years elapsed and the recovery thesis decisively validated by both fundamentals and price, this is a clear win.